Stifel Nicolaus Has Lowered Expectations for Silicon Laboratories (NASDAQ:SLAB) Stock Price

Silicon Laboratories (NASDAQ:SLAB) had its target price cut by Stifel Nicolaus from $145.00 to $120.00 in a research note published on Thursday morning,Benzinga reports. They currently have a buy rating on the semiconductor company’s stock.

Other research analysts also recently issued research reports about the company. StockNews.com cut shares of Silicon Laboratories from a “hold” rating to a “sell” rating in a research report on Thursday, March 27th. Benchmark restated a “buy” rating and issued a $160.00 target price on shares of Silicon Laboratories in a research report on Wednesday, March 12th. KeyCorp increased their price target on shares of Silicon Laboratories from $115.00 to $160.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 22nd. Needham & Company LLC restated a “buy” rating and set a $150.00 price objective on shares of Silicon Laboratories in a research report on Wednesday, March 12th. Finally, Barclays upped their target price on Silicon Laboratories from $75.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Friday, January 17th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $133.70.

Silicon Laboratories Trading Up 0.6 %

Shares of SLAB opened at $90.50 on Thursday. Silicon Laboratories has a 12 month low of $82.82 and a 12 month high of $160.00. The firm’s 50 day moving average is $123.13 and its 200-day moving average is $121.71. The stock has a market capitalization of $2.94 billion, a PE ratio of -15.24 and a beta of 1.33.

Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings data on Tuesday, February 4th. The semiconductor company reported ($0.11) EPS for the quarter, hitting analysts’ consensus estimates of ($0.11). The firm had revenue of $166.25 million for the quarter, compared to analyst estimates of $166.09 million. Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The company’s revenue was up 91.4% on a year-over-year basis. During the same quarter last year, the company earned ($1.19) EPS. Equities research analysts predict that Silicon Laboratories will post -0.97 earnings per share for the current fiscal year.

Insider Activity

In other Silicon Laboratories news, Director Navdeep S. Sooch sold 2,360 shares of the business’s stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total transaction of $351,640.00. Following the sale, the director now directly owns 400,567 shares of the company’s stock, valued at $59,684,483. The trade was a 0.59 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director William G. Bock sold 2,000 shares of the business’s stock in a transaction on Wednesday, January 22nd. The stock was sold at an average price of $140.77, for a total transaction of $281,540.00. Following the completion of the sale, the director now directly owns 32,115 shares in the company, valued at approximately $4,520,828.55. This represents a 5.86 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 5,360 shares of company stock worth $782,610. Insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. MML Investors Services LLC increased its stake in shares of Silicon Laboratories by 5.3% in the third quarter. MML Investors Services LLC now owns 7,328 shares of the semiconductor company’s stock valued at $847,000 after buying an additional 370 shares during the period. Barclays PLC increased its position in Silicon Laboratories by 23.4% during the 3rd quarter. Barclays PLC now owns 70,568 shares of the semiconductor company’s stock valued at $8,157,000 after purchasing an additional 13,363 shares during the period. Geode Capital Management LLC raised its holdings in Silicon Laboratories by 2.1% during the 3rd quarter. Geode Capital Management LLC now owns 781,049 shares of the semiconductor company’s stock worth $90,282,000 after purchasing an additional 15,728 shares during the last quarter. Tidal Investments LLC acquired a new position in shares of Silicon Laboratories in the 3rd quarter worth approximately $520,000. Finally, Franklin Resources Inc. boosted its stake in shares of Silicon Laboratories by 1.9% in the 3rd quarter. Franklin Resources Inc. now owns 231,889 shares of the semiconductor company’s stock valued at $27,001,000 after purchasing an additional 4,278 shares during the last quarter.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.